AU2002224546A1 - Siglec (sialic acid-binding IG-related lectin) polypeptides and uses thereof - Google Patents

Siglec (sialic acid-binding IG-related lectin) polypeptides and uses thereof

Info

Publication number
AU2002224546A1
AU2002224546A1 AU2002224546A AU2454602A AU2002224546A1 AU 2002224546 A1 AU2002224546 A1 AU 2002224546A1 AU 2002224546 A AU2002224546 A AU 2002224546A AU 2454602 A AU2454602 A AU 2454602A AU 2002224546 A1 AU2002224546 A1 AU 2002224546A1
Authority
AU
Australia
Prior art keywords
siglec
bms
protein
nucleic acid
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224546A
Other languages
English (en)
Inventor
Han Chang
Malinda Longphre
Gena Whitney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU2002224546A1 publication Critical patent/AU2002224546A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002224546A 2000-07-21 2001-07-20 Siglec (sialic acid-binding IG-related lectin) polypeptides and uses thereof Abandoned AU2002224546A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22013900P 2000-07-21 2000-07-21
US60/220,139 2000-07-21
PCT/US2001/023082 WO2002008257A2 (fr) 2000-07-21 2001-07-20 Nouveaux siglecs et leurs utilisations

Publications (1)

Publication Number Publication Date
AU2002224546A1 true AU2002224546A1 (en) 2002-02-05

Family

ID=22822232

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224546A Abandoned AU2002224546A1 (en) 2000-07-21 2001-07-20 Siglec (sialic acid-binding IG-related lectin) polypeptides and uses thereof

Country Status (8)

Country Link
US (1) US20030036631A1 (fr)
EP (1) EP1305417A2 (fr)
JP (1) JP2004516012A (fr)
AU (1) AU2002224546A1 (fr)
CA (1) CA2416713A1 (fr)
IL (1) IL153542A0 (fr)
MX (1) MXPA03000514A (fr)
WO (1) WO2002008257A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933223B1 (en) 2004-04-15 2005-08-23 National Semiconductor Corporation Ultra-low loop wire bonding
JP2008502368A (ja) * 2004-06-09 2008-01-31 タノックス, インコーポレイテッド Siglec−6関連疾患の診断および処置
CA2630432A1 (fr) * 2005-11-21 2007-07-19 Genentech, Inc. Nouvelles dissociations de genes, compositions et procedes les concernant
WO2007120815A2 (fr) * 2006-04-12 2007-10-25 The Regents Of The University Of California Procedes destines au traitement de troubles lymphocytaires par modulation de l'activite siglec
WO2009048072A1 (fr) * 2007-10-11 2009-04-16 Daiichi Sankyo Company, Limited ANTICORPS CIBLANT LA PROTÉINE Siglec-15 LIÉE AUX OSTÉOCLASTES
EP2937088B1 (fr) 2012-12-21 2020-11-18 Tokushima University Composition présentant une activité de réparation tissulaire et son utilisation
CA3004972A1 (fr) 2015-11-17 2017-05-26 Innate Pharma Anticorps anti siglec-10
US11359014B2 (en) 2017-05-16 2022-06-14 Alector Llc Anti-siglec-5 antibodies and methods of use thereof
EA202190183A1 (ru) 2018-07-27 2021-05-18 Алектор Ллс Антитела к siglec-5 и способы их применения
CN114414812B (zh) * 2020-12-21 2022-09-20 华中科技大学同济医学院附属同济医院 生物标志物组合在制备暴发性心肌炎诊断试剂及暴发性心肌炎药物方面的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0983078A4 (fr) * 1997-05-27 2003-03-26 Smithkline Beecham Corp Adnc de la famille des sialoadhesines 4 (saf-4)
ES2312205T3 (es) * 1998-03-10 2009-02-16 Genentech, Inc. Nuevo polipeptido y acidos nucleicos que lo codifican.
WO2000059942A2 (fr) * 1999-04-02 2000-10-12 Eli Lilly And Company COMPOSITIONS hOB-BP2h, LEURS TECHNIQUES ET LEURS UTILISATIONS

Also Published As

Publication number Publication date
WO2002008257A2 (fr) 2002-01-31
EP1305417A2 (fr) 2003-05-02
WO2002008257A3 (fr) 2002-12-27
CA2416713A1 (fr) 2002-01-31
JP2004516012A (ja) 2004-06-03
MXPA03000514A (es) 2003-10-06
IL153542A0 (en) 2003-07-06
US20030036631A1 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
EP1539228B1 (fr) Nouvelles composition et methodes servant au traitement de maladies associees au systeme immunitaire
US7041802B2 (en) Peptidoglycan recognition proteins
US20090081727A1 (en) CD33-Like Protein
JP2003523741A (ja) Bcl−2様ポリヌクレオチド、ポリペプチドおよび抗体
KR20040073537A (ko) 종양의 진단 및 치료 방법 및 이를 위한 조성물
WO1998006839A1 (fr) Proteine de type cd44
US20020123617A1 (en) Novel immunoglobulin superfamily members of APEX-1, APEX-2 and APEX-3 and uses thereof
JP2003512819A (ja) B7様ポリヌクレオチド、ポリペプチドおよび抗体
JP2003513622A (ja) 19個のヒト分泌タンパク質
JP2008502368A (ja) Siglec−6関連疾患の診断および処置
AU2002224546A1 (en) Siglec (sialic acid-binding IG-related lectin) polypeptides and uses thereof
US5837841A (en) Human Reg protein
JP2003520049A (ja) ヒトタンパク質であるチロシンホスファターゼのポリヌクレオチド、ポリペプチド、および抗体
CA2447948A1 (fr) Polynucleotide codant un nouveau membre de la famille des canaux trp, trp-plik2, et variant d'epissage de ce polynucleotide
JP2003512856A (ja) ウテログロビン様ポリヌクレオチド、ポリペプチド、および抗体
JP2003508036A (ja) アトラクチン様ポリヌクレオチド、ポリペプチド、および抗体
EP1317553B1 (fr) Pde8a et son utilisations
JP2004500810A (ja) Il−6様ポリヌクレオチド、ポリペプチド、および抗体
AU750543B2 (en) The protein tyrosine kinase substrate LAT and its use in the identification of (ant)agonists of the kinase
JP2003523760A (ja) ヒトポリヌクレオチド、ポリペプチド、および抗体
JP2002537769A (ja) ヒトエンドカインαおよび使用方法
JP2003515325A (ja) 4ジスルフィドコアドメイン含有(fdcd)ポリヌクレオチド、ポリペプチド、および抗体
JP2004500058A (ja) サイトカインレセプター様ポリヌクレオチド、ポリペプチド、および抗体
JP2001502888A (ja) Cd33様タンパク質をコードするヌクレオチド配列
US20030040604A1 (en) Siglec-12 polypeptides, polynucleotides, and methods of use thereof

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application